» Articles » PMID: 38845026

Contribution of CNS and Extra-CNS Infections to Neurodegeneration: a Narrative Review

Overview
Publisher Biomed Central
Date 2024 Jun 6
PMID 38845026
Authors
Affiliations
Soon will be listed here.
Abstract

Central nervous system infections have been suggested as a possible cause for neurodegenerative diseases, particularly sporadic cases. They trigger neuroinflammation which is considered integrally involved in neurodegenerative processes. In this review, we will look at data linking a variety of viral, bacterial, fungal, and protozoan infections to Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis and unspecified dementia. This narrative review aims to bring together a broad range of data currently supporting the involvement of central nervous system infections in the development of neurodegenerative diseases. The idea that no single pathogen or pathogen group is responsible for neurodegenerative diseases will be discussed. Instead, we suggest that a wide range of susceptibility factors may make individuals differentially vulnerable to different infectious pathogens and subsequent pathologies.

Citing Articles

Ancestry-specific gene expression in peripheral monocytes mediates risk of neurodegenerative disease.

Wagen A, Reynolds R, Foo J, Fairbrother-Browne A, Gustavsson E, Galgiano-Turin S bioRxiv. 2025; .

PMID: 39803567 PMC: 11722246. DOI: 10.1101/2024.11.20.624489.


MAD-microbial (origin of) Alzheimer's disease hypothesis: from infection and the antimicrobial response to disruption of key copper-based systems.

Min J, Sarlus H, Harris R Front Neurosci. 2024; 18:1467333.

PMID: 39416952 PMC: 11480022. DOI: 10.3389/fnins.2024.1467333.


Drug Repurposing for COVID-19 by Constructing a Comorbidity Network with Central Nervous System Disorders.

Qian J, Yang B, Wang S, Yuan S, Zhu W, Zhou Z Int J Mol Sci. 2024; 25(16).

PMID: 39201608 PMC: 11354300. DOI: 10.3390/ijms25168917.

References
1.
Gerard H, Wildt K, Whittum-Hudson J, Lai Z, Ager J, Hudson A . The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype. Microb Pathog. 2005; 39(1-2):19-26. DOI: 10.1016/j.micpath.2005.05.002. View

2.
Keane J, Afrasiabi A, Schibeci S, Swaminathan S, Parnell G, Booth D . The interaction of Epstein-Barr virus encoded transcription factor EBNA2 with multiple sclerosis risk loci is dependent on the risk genotype. EBioMedicine. 2021; 71:103572. PMC: 8426200. DOI: 10.1016/j.ebiom.2021.103572. View

3.
Saresella M, Marventano I, Barone M, La Rosa F, Piancone F, Mendozzi L . Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis. Front Immunol. 2020; 11:1390. PMC: 7358580. DOI: 10.3389/fimmu.2020.01390. View

4.
Vogt N, Kerby R, Dill-McFarland K, Harding S, Merluzzi A, Johnson S . Gut microbiome alterations in Alzheimer's disease. Sci Rep. 2017; 7(1):13537. PMC: 5648830. DOI: 10.1038/s41598-017-13601-y. View

5.
Mehrabian S, Raycheva M, Traykova M, Stankova T, Penev L, Grigorova O . Neurosyphilis with dementia and bilateral hippocampal atrophy on brain magnetic resonance imaging. BMC Neurol. 2012; 12:96. PMC: 3517431. DOI: 10.1186/1471-2377-12-96. View